PerpEquities

BeOne Medicines AG (STAR Market shares) (BEIGENE) balance sheet

SHH · Healthcare · Biotechnology · 12,000 employees · CEO John V. Oyler

Price
CN¥248.85 -0.16%
Market cap
CN¥260B
Enterprise value
$35.2B
Last report
Q2 '26 filed 2026-06-30
Next report
2026-11-06

At the end of Q2 '26 BeOne Medicines AG (STAR Market shares) (BEIGENE) held $5.1B in cash and short-term investments against $1.14B of debt incl. leases. Total assets $9.18B, total liabilities $4B, shareholders' equity $5.17B.

Balance sheet

Balance sheetTrendQ3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Assets
Cash & equivalents$3.07B$3.17B$2.79B$2.59B$2.7B$2.63B$2.52B$2.76B$4.04B$4.58B$4.85B$5.1B
Short-term investments$107M$2.6M$0$0$0$0$0$0$0$0$0$0
Receivables$355M$396M$467M$529M$603M$709M$746M$880M$863M$886M$952M$1.07B
Inventory$317M$416M$447M$443M$432M$495M$495M$503M$532M$608M$684M$733M
Other current assets$154M$167M$149M$198M$30.8M$25.2M$32.4M$36.3M$203M$18.9M$45.4M$208M
Current assets$4.05B$4.2B$3.91B$3.84B$3.91B$3.99B$3.9B$4.31B$5.66B$6.23B$6.63B$7.22B
Property, plant & equipment (net)$1.29B$1.42B$1.55B$1.62B$1.71B$1.66B$1.76B$1.77B$1.77B$1.79B$1.79B$1.79B
Long-term investments$89.3M$89.6M$144M$140M$138M$129M$121M$119M$101M$82.4M$87.2M$66.1M
Intangible assets$53.7M$57.1M$55.2M$53.7M$53.9M$130M$50.1M$64.9M$63.6M$62.6M$61.9M$61M
Deferred tax assets$30.3M$2.55M$2.76M$2.6M$0$0$0$0$0$44M$0$0
Other non-current assets$8.95M$35.7M$8.77M$56.9M$14.2M$13.4M$13.1M$37.4M$35.5M$19.9M$17.4M$38.9M
Non-current assets$1.47B$1.6B$1.76B$1.87B$1.92B$1.93B$1.95B$1.99B$1.97B$2B$1.96B$1.96B
Total assets$5.52B$5.81B$5.67B$5.71B$5.83B$5.92B$5.84B$6.3B$7.63B$8.22B$8.59B$9.18B
Liabilities
Accounts payable$342M$315M$357M$333M$308M$405M$364M$361M$384M$479M$425M$470M
Accrued expenses$443M$427M$482M$559M$437M$499M$460M$549M$867M$305M$158M$827M
Short-term debt$329M$688M$827M$852M$864M$852M$763M$808M$813M$57.3M$189M$191M
Taxes payable$43.3M$53M$74.6M$53.7M$49.4M$60.8M$115M$115M$0$0$0$226M
Deferred revenue$526M$717M$597M$0$0$0$0$0$0$0$0$0
Other current liabilities$147M$196M$197M$177M$316M$360M$243M$342M$289M$924M$962M$343M
Current liabilities$1.28B$1.81B$1.88B$1.94B$2.03B$2.21B$1.98B$2.21B$2.37B$1.83B$1.82B$2.12B
Long-term debt$202M$198M$199M$185M$188M$166M$160M$146M$140M$1.81B$1.79B$882M
Lease obligations (non-current)$25.5M$22.3M$17.7M$35.4M$32.5M$44.3M$54.9M$53.9M$51.4M$52.9M$49.9M$48.2M
Deferred revenue (non-current)$34.2M$34.2M$32.9M$32M$32.4M$30.3M$29.8M$29.6M$29.1M$29M$28.7M$28.5M
Deferred tax liabilities$16.4M$16.5M$16.4M$15.9M$15.9M$42M$43.1M$44.1M$47.1M$97.1M$56.1M$57.4M
Other non-current liabilities$250M$238M$209M$186M$101M$90.7M$70.3M$44.4M$944M$51.2M$53.4M$866M
Non-current liabilities$478M$458M$426M$407M$369M$374M$358M$318M$1.13B$2.01B$1.98B$1.88B
Total liabilities$1.76B$2.27B$2.31B$2.35B$2.39B$2.59B$2.34B$2.53B$3.5B$3.84B$3.78B$4B
Equity
Common stock & paid-in capital$135K$135K$136K$137K$138K$138K$140K$143K$144K$144K$145K$147K
Retained earnings-$7.59B-$7.96B-$8.21B-$8.33B-$8.45B-$8.61B-$8.61B-$8.51B-$8.39B-$8.31B-$8.12B-$7.86B
Accumulated other comprehensive income-$145M-$99.4M-$132M-$140M-$83.5M-$149M-$142M-$114M-$101M-$78.1M-$53.7M-$25.4M
Shareholders' equity$3.76B$3.54B$3.36B$3.37B$3.44B$3.33B$3.5B$3.77B$4.13B$4.36B$4.78B$5.17B
Debt
Total debt (incl. leases)$580M$930M$1.06B$1.09B$1.1B$1.08B$997M$1.03B$1.02B$2B$2.06B$1.14B
Net debt (debt - cash)-$2.49B-$2.24B-$1.73B-$1.5B-$1.6B-$1.55B-$1.52B-$1.73B-$3.02B-$2.59B-$2.79B-$3.95B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates: Financial Modeling Prep.

Data as of 2026-11-02 · Amounts in USD as reported; price and market cap in CNY.